Zheyu Zhuang
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Correction: Exploring the role of ferroptosis in pemphigus: identification of diagnostic markers and regulatory mechanisms.
Journal: Frontiers in medicine
Published: June 04, 2026
Atypical tinea corporis with Id reaction: A case report and successful treatment with upadacitinib.
Journal: IDCases
Published: April 30, 2025
Efficacy and safety of switching from baricitinib to ritlecitinib in severe alopecia areata.
Journal: Clinical and experimental dermatology
Published: September 27, 2024
Effective Treatment of Recalcitrant Generalized Papular Granuloma Annulare With Upadacitinib Monotherapy: A Case Report and Literature Review.
Journal: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
Published: September 11, 2024
Effectiveness and safety of methylprednisolone combination with abrocitinib compared to methylprednisolone combination with azathioprine in bullous pemphigoid: a retrospective study.
Journal: Scientific reports
Published: September 03, 2024
Evaluation of combination therapy with ofatumumab and systemic corticosteroids for pemphigus: A multi-centre cohort study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 17, 2024
Application and Comparison of Dermoscopy and Reflectance Confocal Microscopy in the Target Treatment of Genital Lichen Sclerosus: A Single-Arm Prospective Study.
Journal: Dermatology and therapy
Published: July 07, 2023
Efficacy and tolerability of oral upadacitinib monotherapy in patients with recalcitrant vitiligo.
Journal: Journal of the American Academy of Dermatology
Published: July 04, 2023
Decoding real-world outcomes: Exploring clinical features associated with efficacy in patients treated with dupilumab.
Journal: Journal of the American Academy of Dermatology
Published: June 14, 2023
An observational study of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab.
Journal: Journal of the American Academy of Dermatology
Published: March 20, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026